Press release
Global Parkinson's Disease Market to Reach $4.98 Billion by 2029, Growing at 8.2% CAGR
Parkinson's Disease
The increasing prevalence of neurodegenerative diseases is expected to propel the growth of the Parkinson's disease market. Neurodegenerative diseases, which involve the progressive degeneration of neurons, are becoming more prevalent due to factors such as aging populations, genetic predisposition, and environmental influences. Parkinson's disease research provides critical insights into these diseases, advancing therapeutic targets and treatment approaches. For instance, the European Brain Council reported that over 600 neurological diseases affect millions globally, with projections indicating the number of people with dementia in Europe will rise from 10.5 million in 2023 to 18.7 million by 2050. The increasing prevalence of neurodegenerative diseases, including Parkinson's disease, is driving the growth of the Parkinson's disease market.
Get Your Parkinson's Disease Market Report Here:
https://www.thebusinessresearchcompany.com/report/parkinsons-disease-global-market-report
How will the growth rate of the parkinson's disease market shape industry trends by 2034?
The Parkinson's disease market has also seen strong growth, increasing from $3.34 billion in 2024 to $3.63 billion in 2025 at a CAGR of 8.5%. Growth has been driven by increasing research and development, higher government funding, growth in personalized treatment plans, expansion of support networks for Parkinson's disease patients, and increased use of advanced rehabilitation therapies.
The Parkinson's disease market is anticipated to experience strong growth, reaching $4.98 billion by 2029, at a CAGR of 8.2%. Growth drivers include greater awareness of Parkinson's symptoms, increased government initiatives, rising healthcare investments, expanding clinical trials, and growing adoption of gene therapies. Expected trends involve technological innovations, government funding, AI-driven diagnosis, new treatment solutions, and advancements in personalized medicine.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21247&type=smp
What trends are poised to drive the future success of the parkinson's disease market?
In the Parkinson's disease market, companies are focused on developing levodopa-based therapies to improve motor function and manage symptoms, especially for patients with advanced stages of the disease. Levodopa is a well-established treatment that converts into dopamine in the brain, addressing the motor symptoms of Parkinson's. For instance, in October 2024, AbbVie Inc., a US-based biopharmaceutical company, received FDA approval for VYALEV, a combination therapy containing levodopa and carbidopa. This formulation aims to improve the effectiveness of levodopa by inhibiting its breakdown before it reaches the brain, ensuring better management of symptoms like tremors, rigidity, and bradykinesia.
Which primary segments of the parkinson's disease market are driving growth and industry transformations?
The parkinson's disease market covered in this report is segmented -
1) By Drug Class: Dopamine Agonists, Catechol-O-Methyltransferase Inhibitors, Monoamine Oxidase B Inhibitors, Anticholinergics, Carbidopa-Levodopa, Other Drug Classes
2) By Route Of Administration: Oral, Injectable, Intestinal infusion, Subcutaneous, Other Route Of Administrations
3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Pharmacies
4) By Patient Care Setting: Clinics, Hospitals
Subsegments:
1) By Dopamine Agonists: Ergot Derivatives, Non-Ergot Derivatives
2) By Catechol-O-Methyltransferase (COMT) Inhibitors: Entacapone, Tolcapone, Opicapone
3) By Monoamine Oxidase B (MAO-B) Inhibitors: Selegiline, Rasagiline, Safinamide
4) By Anticholinergics: Trihexyphenidyl, Benztropine, Procyclidine
5) By Carbidopa-Levodopa: Immediate-Release Formulation, Extended-Release Formulation, Inhaled And Intestinal Gel Formulations
6) By Other Drug Classes: Amantadine And Derivatives, Adenosine A2A Receptor Antagonists, Glutamate Antagonists
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21247
Which geographical regions are pioneering growth in the parkinson's disease market?
North America was the largest region in the parkinson's disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the parkinson's disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the influential players reshaping the parkinson's disease market landscape?
Major companies operating in the parkinson's disease market are Roche Holding AG, AbbVie Inc., Novo Nordisk A/S, Takeda Pharmaceutical Company Limited, UCB S.A., Eisai Co. Ltd., Kyowa Kirin Co. Ltd., Amneal Pharmaceuticals Inc., Neurocrine Biosciences Inc., Supernus Pharmaceuticals Inc., Sunovion Pharmaceuticals Inc., Intracellular Therapies Inc., Voyager Therapeutics Inc., Sage Therapeutics Inc., Adamas Pharmaceuticals Inc., Sun Pharma Advanced Research Company Ltd., Neuraly Inc., Mitsubishi Tanabe Pharma Corporation, Athira Pharma Inc., VistaGen Therapeutics Inc.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=21247&type=smp
What Is Covered In The Parkinson's Disease Global Market Report?
•Market Size Forecast: Examine the parkinson's disease market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the parkinson's disease market for a structured understanding.
•Key Players Overview: Analyze major players in the parkinson's disease market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the parkinson's disease market.
•Segment Contributions: Evaluate how different segments drive overall growth in the parkinson's disease market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the parkinson's disease market.
•Industry Challenges: Identify potential risks and obstacles affecting the parkinson's disease market.
•Competitive Landscape: Review strategic developments in the parkinson's disease market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Parkinson's Disease Market to Reach $4.98 Billion by 2029, Growing at 8.2% CAGR here
News-ID: 3934567 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Parkinson
Key Trends Reshaping the Wolff Parkinson White Syndrome Market: Technological Ad …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Wolff Parkinson White Syndrome Market Size Growth Forecast: What to Expect by 2025?
The market for Wolff Parkinson White syndrome has registered consistent growth over the recent past. The expectation is that it will expand from $1.17 billion in 2024 to $1.22 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.5%.…
Evolving Market Trends In The Anti-Parkinson Drugs Industry: Innovative Advancem …
The Anti-Parkinson Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Anti-Parkinson Drugs Market Size During the Forecast Period?
The anti-parkinson drugs market has seen significant growth in recent years, projected to increase from $10.37 billion in 2024 to $11.08 billion in…
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market?
In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced…
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market?
In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced…
Wolff Parkinson White Syndrome Treatment Market Overview 2024-2033
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Wolff Parkinson White Syndrome Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $1.43 billion…
Anti-Parkinson Drugs Market Overview
Exhibiting robust growth, the anti-parkinson drugs market is set to escalate from $9.73 billion in 2023 to $10.43 billion in 2024, with a notable Compound Annual Growth Rate (CAGR) of 7.2%. The trajectory continues on an upward trend, with an anticipated market size of $13.36 billion by 2028, sustaining a robust CAGR of 6.4%.
Increasing Geriatric Population Driving Demand:
The burgeoning geriatric population, coupled with a surge in Parkinson's disease cases,…
